|
TAF11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.786200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.186100E-02 |
| Normal-vs-Stage2 |
4.335200E-01 |
| Normal-vs-Stage3 |
3.090800E-01 |
| Normal-vs-Stage4 |
8.932800E-01 |
| Stage1-vs-Stage2 |
7.023200E-01 |
| Stage1-vs-Stage3 |
9.894600E-01 |
| Stage1-vs-Stage4 |
4.501000E-01 |
| Stage2-vs-Stage3 |
7.816800E-01 |
| Stage2-vs-Stage4 |
6.794600E-01 |
| Stage3-vs-Stage4 |
5.702200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.762300E-02 |
| Normal-vs-AfricanAmerican |
1.431630E-02 |
| Normal-vs-Asian |
3.281400E-01 |
| Caucasian-vs-AfricanAmerican |
1.776790E-01 |
| Caucasian-vs-Asian |
9.080600E-01 |
| AfricanAmerican-vs-Asian |
6.897400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.629500E-02 |
| Normal-vs-Female |
4.046200E-02 |
| Male-vs-Female |
4.617000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.807400E-01 |
| Normal-vs-Extreme_Weight |
1.530380E-01 |
| Normal-vs-Obese |
5.014200E-02 |
| Normal-vs-Extreme_Obese |
7.926000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.053800E-01 |
| Normal_Weight-vs-Obese |
2.304400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.008200E-01 |
| Extreme_Weight-vs-Obese |
4.835000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.044400E-01 |
| Obese-vs-Extreme_Obese |
4.015000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.841710E-02 |
| Normal-vs-Age(41-60Yrs) |
4.135400E-03 |
| Normal-vs-Age(61-80Yrs) |
2.888000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.206400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.215800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.100200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.388300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.246400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.270400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.387800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.648840E-04 |
| Normal-VS-Type2 PRCC |
1.554820E-01 |
| Normal-VS-KIRP CIMP |
3.007200E-01 |
| Normal-VS-Unclassified PRCC |
5.782600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.65900000403951E-08 |
| Type1 PRCC-VS-KIRP CIMP |
8.171000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.655560E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.924400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.808200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.498000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.422400E-01 |
| Normal-vs-N1 |
6.777500E-02 |
| Normal-vs-N2 |
7.720000E-02 |
| N0-vs-N1 |
1.013220E-01 |
| N0-vs-N2 |
1.487370E-01 |
| N1-vs-N2 |
1.120820E-01 |
|
|
